This educational programme focuses on putative mechanistic links between epilepsy and cardiovascular disease, raises clinically relevant questions about anti-epileptic drug use in the context of cardiac disease, and addresses unresolved issues of practical importance in this area of “neuro-cardiology”.
QT prolongation associated with the use of anti-epileptic drugs (AEDs)
09/02/2015 - Long QT syndrome and epilepsy -
06/26/2015 - Management of angina and the role of Ranolazine in the context of the NICE guidelines -
06/26/2015 - Clinical cases where an indication for ranolazine may exist - Dr Rajan Sharma, St Geroge's University of London
06/26/2015 - Antianginal agents: Beneficial effects of Ranolazine -
06/26/2015 - Guidelines (ESC & NICE) for the pharmacological management of angina pectoris – What’s new? -
06/26/2015 - Pharmacological treatment of stable angina – Conventional and novel anti-anginal agents - Dr Amelia Carro Hevia, Corvilud Institute, Spain